Novavax's COVID-19 booster is now authorized in Europe

Shares of Novavax Inc. were up 2.4% in trading on Monday after the company said its COVID-19 booster has been authorized in Europe for adults. Novavax's stock has declined 77.3% so far this year, while the S&P 500 is down 14.6%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.